Givaudan | GIVN - Cash And Equivalent


Givaudan reported CHF603M in Cash and Equivalent for its fiscal semester ending in June of 2024.





Cash And Equivalent Change Date
Air Liquide EUR 3.96B 2.05B Dec/2025
Akzo Nobel EUR 1.62B 66M Dec/2025
Anheuser-Busch USD 11.53B 4.47B Dec/2025
Arkema EUR 2.19B 235M Dec/2025
Associated British Foods GBP 1.06B 299M Jun/2025
BASF EUR 2.67B 811M Dec/2025
Bayer EUR 6.67B 774M Dec/2025
Beiersdorf EUR 1.2B 33M Dec/2025
British American Tobacco GBP 4.4B 1.53B Jun/2025
Covestro EUR 648M 44M Dec/2025
Croda International GBP 157.8M 9M Jun/2025
Danone EUR 1.98B 364M Dec/2025
Diageo GBP 2.2B 544M Jun/2025
Fresenius EUR 1.31B 81M Dec/2025
Fresenius Medical Care EUR 1.24B 343.37M Mar/2026
Givaudan CHF 603M 3M Jun/2024
Glanbia EUR 417M 116.1M Jan/2025
Heineken EUR 2.07B 284M Jun/2025
Henkel EUR 2.71B 163M Dec/2025
International Flavors Fragrances USD 562M 28M Mar/2026
Johnson Matthey GBP 542M 49M Jun/2024
Lonza CHF 719M 188M Dec/2025
L'Oréal EUR 9.86B 5.04B Dec/2025
Merck EUR 2.33B 77M Dec/2025
Nestle CHF 4.58B 73M Dec/2025
Pernod Ricard EUR 2.4B 569M Dec/2025
Reckitt Benckiser GBP 880M 106M Dec/2024
SGS CHF 1.21B 78M Dec/2024
Sika AG CHF 1.87B 1.18B Dec/2022
Solvay EUR 486M 50M Mar/2026
Tate & Lyle GBP 475M 41M Jun/2023
Umicore EUR 1.56B 450.17M Dec/2025
Victrex GBP 58.7M 13M Dec/2022